clinicalomicsprowebdirectory
News
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Marketplace
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News
Antibiotics
Original Penicillium Mold Genome Could Point to New Routes for Industrial…
Molecular Dx
New Cardiac Cell Atlas Could Fuel Personalized Heart Treatments
Coronavirus
Wide Variety in Accuracy of COVID-19 Antibody Tests Revealed
Coronavirus
Large Phase III Trial Launched for J&J’s COVID-19 Vaccine
Oncology
CRISPR Identifies Genes Allowing Cancer to Evade Immune Detection
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Antibiotics
Original Penicillium Mold Genome Could Point to New Routes for Industrial…
Molecular Dx
New Cardiac Cell Atlas Could Fuel Personalized Heart Treatments
Coronavirus
Wide Variety in Accuracy of COVID-19 Antibody Tests Revealed
Coronavirus
Large Phase III Trial Launched for J&J’s COVID-19 Vaccine
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 2
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Marketplace
Multimedia
All
Webinars
eBooks
Upcoming Webinars
Predicting Breast Cancer Outcomes Using AI Models and Federated Learning
Upcoming Webinars
Whole-Genome Sequencing Comes of Age in Clinical Care
Multimedia
Navigating Complexity in Oncology Cell and Gene Therapy Clinical Trials
Multimedia
Sequencing Controls Improve Confidence in NGS Patient Results
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Precision Medicine
Technology
Technology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Technology
10 Leading Immuno-Oncology Startups
March 25, 2019
Technology
Mammoth Competition: Feng Zhang, Partners Launch CRISPR Dx Company
March 22, 2019
Technology
Viome, Helomics Partner on Personalized Ovarian Cancer Treatments
March 21, 2019
Technology
TGen Launches Software to ID Tumor-Causing Mutations from Archival Tumor Samples
March 21, 2019
Technology
Ambry and My Gene Counsel Team Up on Tests to Confirm...
March 19, 2019
Technology
Broad Institute, Pattern.org, LUNGevity Foundation Partner to Develop Lung Cancer Models
March 18, 2019
Technology
UK Commits £45M Toward Capacity Expansion at EMBL-EBI
March 15, 2019
Technology
Myriad Genetics Gets Medicare Coverage for myPath Melanoma Test
March 14, 2019
Technology
Lucence, Stanford Researcher to Develop AI Algorithms for Liver Cancer Treatment
March 14, 2019
Technology
BGI Genomics to Commercialize Natera’s Signatera Assay in China
March 13, 2019
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Myriad Genetics has received a final local coverage determination for its myPath Melanoma test from the Medicare Administrative Contractor Palmetto GBA MolDx. [Myriad Genetics]](https://www.clinicalomics.com/wp-content/uploads/2019/03/2189-324x160.jpeg "Myriad Genetics Gets Medicare Coverage for myPath Melanoma Test")
![Lucence Diagnostics will partner with a Stanford University researcher to develop AI algorithms designed to improve the diagnosis and treatment of liver cancer. [Lucence Diagnostics]](https://www.clinicalomics.com/wp-content/uploads/2019/03/2187-324x160.jpeg "Lucence, Stanford Researcher to Develop AI Algorithms for Liver Cancer Treatment")
